Cardiac ICU neuromonitoring in infants with CHD leads to early arterial ischaemic stroke recognition: a single centre experience
Koerner TS, Farley M, Tien A, Baust T, Commander B, Guzman C, Cummings D, Gazit A and Lin JI
Evaluate the utility of comprehensive neuromonitoring to allow for early identification of arterial ischaemic strokes in high-risk critically ill infants with CHD.
Impact of impaired foetal maternal environment on neonates with CHD: are we ready for the mother-baby dyad?
Savla J, Schumacher K, Mikesell K, Banerjee M, Ball M, Bhat P, Bhat A, Bhatt S, Chan T, Chaudhry P, Frank DU, Killen S, Krishnan A, Mistry K, Neumayr TM, Patel A, Savorgnan F, Son S, Zakaria D, Tabbutt S and Steurer M
Emerging evidence suggests that an impaired foetal environment-defined as maternal factors such as hypertensive disorders and diabetes-might contribute to outcomes in neonates with CHD. With this multicentre study, we prospectively collected data regarding impaired foetal environment to assess the impact on mortality in two ventricle and single ventricle neonates with CHD.
Proactive versus resuscitative extracorporeal membrane oxygenation for low cardiac output syndrome after cardiac surgery
Halloum A, Tabbutt S, Ghanayem N, Lasa JJ, Banerjee M, Zhang W, Mikesell K, Charpie JR, McCammond AN, Moynihan KM, Panchal A, Raymond TT and Steurer MA
We sought to evaluate extracorporeal membrane oxygenation (ECMO) use for low cardiac output syndrome (LCOS) after congenital heart surgery. Our primary aims were (1) to compare hospital mortality and morbidity for proactive ECMO versus extracorporeal cardiopulmonary resuscitation (ECPR) and (2) to assess the impact of cardiopulmonary resuscitation (CPR) duration. Our secondary aim was to investigate pre-ECMO vasoactive inotropic scores (VIS).
Role of Home Monitoring in Reducing Disparities in the Interstage Mortality of Infants with Single Ventricle
El-Magharbel Y, Goldberg CS, Yu S, Valentini A, Uzark K, Romano JC, Fifer CG, Afton KM, Lowery R, Duimstra A and Balasubramanian S
To determine whether the interstage (between Norwood and stage 2 palliation) home monitoring program (IHMP) has reduced disparities in interstage survival and growth outcomes in patients with single-ventricle heart disease.
Early Neurodevelopmental Outcomes in Children With Congenital Heart Disease
Seed M, Ilardi D, Rofeberg V, Ortinau C, Goldberg C, Reichle G, Bush L, Elhoff J, Lisanti AJ, Butcher J, Rollins C, Van Bergen A, Peyvandi S, Bucholz E, Cox S, Hampton L, Sanz J, Monteiro S, Tewar S, Allen K, Lee C, Glotzbach K, Alexander N, Bear L, Anton C, Sananes R, Ly L, Boucher G, Wolfe K, Edwards L, Willen E, Tan A, Ortega C, Sood E, Sadhwani A, Plant KC, Quigley L, Pliego J, Valles E, Hines A, Wypij D and Miller T
Neurodevelopmental impairments are common in children with congenital heart disease.
